(BNR) Brenntag SE - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE000A1DAHH0

BNR: Industrial Chemicals, Specialty Chemicals, Ingredients

Brenntag SE is a global leader in chemical distribution, operating across Europe, the Middle East, Africa, the Americas, and the Asia Pacific. Founded in 1874 and headquartered in Essen, Germany, the company has built a robust platform for sourcing, storing, and delivering industrial and specialty chemicals. Brenntag operates through two core segments: Brenntag Essentials, which focuses on industrial chemicals, and Brenntag Specialties, which caters to higher-margin specialty chemicals. This dual approach allows the company to balance volume-driven industrial sales with the precision and customization required for specialty markets.

The company’s value proposition lies in its ability to provide end-to-end solutions for chemical distribution. Brenntag offers just-in-time delivery, product mixing, blending, and repackaging, as well as inventory management and drum return handling. This comprehensive service model is critical for industries where supply chain efficiency and product handling are paramount. Brenntag serves a diverse range of end markets, including nutrition, pharma, personal care, water treatment, and lubricants, as well as home, industrial, and institutional markets. It also has a strong presence in coatings, constructions, polymers, and rubber industries.

From a financial perspective, Brenntag SE is a large-cap company with a market capitalization of 8,683.31 million EUR. The stock trades on the XETRA exchange under the ticker symbol BNR. The company’s trailing P/E ratio of 14.63 and forward P/E of 10.86 suggest that investors are pricing in moderate growth expectations. The price-to-book ratio of 2.00 indicates that the market values the company’s assets at a premium, likely due to its strong distribution network and intangible assets like customer relationships. The price-to-sales ratio of 0.54 reflects the company’s ability to generate revenue from its extensive operations.

For investors and fund managers, Brenntag SE’s appeal lies in its stable cash flows, driven by long-term contracts with suppliers and customers. The company’s scale and global reach provide a competitive advantage, as it can negotiate favorable terms with chemical manufacturers and pass economies of scale to its customers. Brenntag’s focus on sustainability and safety in chemical handling also aligns with the growing emphasis on ESG criteria in investment decisions. However, the company’s profitability is sensitive to fluctuations in chemical prices and global demand, making it important to monitor macroeconomic trends and industry dynamics.

Additional Sources for BNR Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

BNR Stock Overview

Market Cap in USD 9,079m
Sector Basic Materials
Industry Specialty Chemicals
GiC Sub-Industry Specialty Chemicals
IPO / Inception

BNR Stock Ratings

Growth Rating 13.1
Fundamental 39.0
Dividend Rating 92.4
Rel. Strength -17.7
Analysts -
Fair Price Momentum 56.26 EUR
Fair Price DCF 85.91 EUR

BNR Dividends

Dividend Yield 12m 6.98%
Yield on Cost 5y 12.00%
Annual Growth 5y 10.93%
Payout Consistency 100.0%

BNR Growth Ratios

Growth Correlation 3m -31.3%
Growth Correlation 12m -63.5%
Growth Correlation 5y 23.2%
CAGR 5y 9.96%
CAGR/Max DD 5y 0.27
Sharpe Ratio 12m -0.71
Alpha -27.53
Beta 0.481
Volatility 32.51%
Current Volume 527.2k
Average Volume 20d 364.9k
What is the price of BNR stocks?
As of April 24, 2025, the stock is trading at EUR 56.66 with a total of 527,249 shares traded.
Over the past week, the price has changed by +1.00%, over one month by -10.40%, over three months by -1.32% and over the past year by -22.54%.
Is Brenntag SE a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Brenntag SE (XETRA:BNR) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 38.96 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BNR as of April 2025 is 56.26. This means that BNR is currently overvalued and has a potential downside of -0.71%.
Is BNR a buy, sell or hold?
Brenntag SE has no consensus analysts rating.
What are the forecast for BNR stock price target?
According to ValueRays Forecast Model, BNR Brenntag SE will be worth about 60.8 in April 2026. The stock is currently trading at 56.66. This means that the stock has a potential upside of +7.24%.
Issuer Forecast Upside
Wallstreet Target Price 74.2 30.9%
Analysts Target Price - -
ValueRay Target Price 60.8 7.2%